Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune mediated neuropathies.
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
Riboflavin Supplementation to Patients with Multiple Sclerosis does not Improve Disability Status nor is Riboflavin Supplementation Correlated to Homocysteine.
Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening.
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
[Autonomic nervous system alteration in multiple sclerosis patients with urinary symptoms. Clinical, urodynamic and cardiovascular study].
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity.
Treatment with interferon beta for multiple sclerosis.
Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review.
Early versus delayed treatment with laquinimod demonstrated significant reduction in risk of disability progression – Results of three-year ALLEGRO study in relapsing-remitting multiple sclerosis
The structure and function of the S1P1 receptor.
Subject movement during multislice interleaved MR acquisitions: Prevalence and potential effect on MRI-derived brain pathology measurements and multicenter clinical trials of therapeutics for multiple sclerosis.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study.
Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation.
No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients.
Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study.
Reducing falls and improving mobility in multiple sclerosis.
Bacillus thuringiensis poisoning related acute transverse myelitis.
Reconstruction of the human cerebral cortex robust to white matter lesions: Method and validation.
Designed Glucopeptides Mimetics of Myelin Protein Epitopes As Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis.
Signalling Pathways that Inhibit the Capacity of Precursor Cells for Myelin Repair.
A review of current and emerging therapeutic strategies in multiple sclerosis.
A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease.
Pages
« first
‹ previous
…
305
306
307
308
309
310
311
312
313
…
next ›
last »